(2) of Saccharomyces cerevisiae, Slp1 (5) 
expression pattern of p55Cdc during development is restricted to tissues that are actively dividing, e.g., hematopoietic organs including liver, spleen, and p55Cdc is a mammalian protein that exhibits high thymus (6). Immune complexes of p55Cdc contain homology to cell cycle proteins Cdc20p (1) and Hct1 kinase activity that was higher in actively proliferating cells than in quiescent cells and fluctuated with
In synchronized cells, p55Cdc is also regulated durin RPMI medium with 10% fetal bovine serum (FBS), L-glutamine (2 mM), and penicillin (100 U/ml)-streping the cell cycle, with a rise in protein levels at the G 1 to S transition (10).
tomycin (100 mcg/ml) at a ratio of 1 U/ml:1 mcg/ml in nonadherent tissue culture plates. Cells were To begin studying the regulation of p55Cdc expression during the cell cycle, we undertook experiments maintained on 500 pM recombinant human GM-CSF (rhGM-CSF). The TF-1 cells (10 7 total per electroporto determine the structure, promoter region, enhancer activity, and localization of the gene. Localation) were centrifuged at 1000 rpm for 5 min and resuspended in 0.25 ml of RPMI with 0.5% bovine ization of several cell cycle genes has revealed their potential association with malignant diseases. Muserum albumin (BSA). Cells were electroporated (BioRad, Hercules, CA) at 200 V and a capacitance of tations and deletions of cyclin D and Ink4 genes have been described in neoplasms such as lymphomas, 960 mF. A total of 25 mcg of the 01000p55CdcCAT promoter construct and 3 mcg of a CMV b-galactosiparathyroid tumors, and leukemias (12). In this paper, we demonstrate that the p55Cdc promoter condase plasmid was transfected into cells. The CMV bgalactosidase plasmid was used as the internal contains enhancer activity through potentially critical DNA-binding proteins (e.g., c-myc), and that the trol for transfection efficiency. Following transfection, cells were placed in RPMI with 10% FBS for 24 h p55Cdc gene is located in a region that is deleted in carcinomas and leukemias (13 -15 centage acetylation of 01000p55CdcCAT activity by a low-stringency screening of a rat genomic library percentage acetylation of the pCAT vector control with a cDNA encoding the rat a-2,6-sialyltransferplasmid. Corrected fold induction was further divided ase, as previously described (6). The DNA sequence by the difference in the CMV b-galactosidase activity was determined using Sequenase (U.S. Biochemical, measured in 01000p55CdcCAT and the pCAT vector Cleveland, OH) and following the manufacturer's transfections. protocol. Sequencing was also performed on the Applied Biosystems 373A automated DNA sequencer Localization of the p55Cdc Gene by Radiation with the Tag Dye Deoxy Terminator kit.
Hybrid Mapping Preparation of the 01000p55Cdc Promoter
Primers were designed to amplify a 193-bp fragConstruct ment from human genomic DNA (17). The primers The 1000-nucleotide (nt) region of the rat p55Cdc used for the amplification were 5-CACAGTTCGCGpromoter was isolated by PCR, using specific primers TTCGAGAGT-3 (sense coding strand nt /5 to /24) containing restriction sites. For the 5 primer (5-and 5-GAACTGGATTTGCCAGGAGT-3 (antisense CCCAAGCTTGGGGCTTCCCTTCTTC-3), a Hincoding strand, nt /175 to /194). PCR reactions condIII site was introduced at the 5 end. For the 3 tained 10 mM TrisCl (pH 9.0), 50 mM KCl, 0.1%Triton primer (5-GCTCTAGAGCTCTCCGCTGCTAGTGT-X, 0.01% gelatin, 1.5 mM MgCl 2 , 150 mM dNTPs, 20 TCAT-3 ), an XbaI site was engineered. PCR was ng genomic DNA, and 1 mM of each primer. PCR performed with an annealing temperature of 50ЊC cycling conditions consisted of an initial denaturation for 40 cycles (Perkin-Elmer, Foster City, CA). The at 95ЊC for 5 min, followed by 30 cycles at 94ЊC for 01000 nt region was subcloned into the pCAT vector 30 s, 62ЊC for 45 s, 72ЊC for 45 s, and a final extension (Promega, Madison, WI) and digested with HindIII at 72ЊC for 6 min. A single PCR product of the exand XbaI. The promoter sequence was verified by pected size was detected by gel electrophoresis in automated sequencing at Amgen, Inc. (Thousand 1.2% agarose from human genomic DNA but not from Oaks, CA).
hamster DNA. The GeneBridge 4 radiation hybrid panel consisting of genomic DNA from 93 radiation Cell Culture and Transfections of p55Cdc Promoter hybrid clones, a human cell clone, and the hamster Construct recipient cell clone was subjected to PCR. Fragments were electrophoresed in 1.2% agarose gels, and the The human factor-dependent myeloid leukemic cell line, TF-1, was obtained from the ATCC and cultured DNA fragments visualized with ethidium bromide staining. The typing data vector was 01000100 lian gene is conserved in the Drosophila gene. A search of the GenBank database revealed a human 01000000 00101000 01100010 01000000 11100000 01001000 10011100 01000001 11100000 10000000 genomic fragment (Accession Number Z61997) with conservation of the exon 2 and exon 3 bound-00000. The results were sent through the Internet at http://www-genome.wi.mit.edu/cgi-bin/contig/ aries, suggesting that the gene organization may be conserved between these species. rhmapper.pl, and results were returned by e-mail.
Sequence of the p55Cdc Promoter

RESULTS AND DISCUSSION
To begin our studies on the regulation of p55Cdc Characterization of the p55Cdc Gene gene expression, we sequenced the p55Cdc promoter. The sequence of the promoter region re-A rat genomic library made from a partial EcoR1 vealed the cell cycle regulatory motifs first dedigest ligated into Charon 4A (Clontech, Palo Alto, scribed in the cdc25 promoter (18) and subse-CA) was used to isolate a p55Cdc genomic clone quently for the regulation of cyclin A, p34cdc2 (19), (6). A region of about 5.2 kb encompassing all 10 and CENP-A (20) (Fig. 2) . The motifs described as exons was sequenced, and the data deposited. ) suggested that primer extension failed to reveal any upstream CDE/CHR-directed repression of a specific set of transcription start sites. Furthermore, the 10 extranscription factors such as SP1 and NFY during ons add up to 1767 bp, which is close to the 2.0-kb G 0 and early G 1 phases of the cell cycle accounts size estimation for the p55Cdc mRNA (6). The exon/ for the regulated expression of cdc25C, cyclin A, intron boundaries are well conserved and mostly and p34cdc2 at G 1 /S. The expression of p55Cdc has follow the canonical AGgt(a/g) sequence (Fig. 1B) .
been demonstrated to initiate at the G 1 /S transition The Drosophila homologue, fizzy, has only two in-(6,10), and it is possible that it is regulated by a trons (3), and the second exon/intron junction of similar mechanism. fizzy is homologous to the mammalian p55Cdc gene Another interesting feature of the p55Cdc gene is exon 4/intron 4 junction. It is intriguing that one the large number of E-box motifs conforming to the of two noncanonical splice junctions in the mammaconsensus CANNTG found in the gene. However, only 4 of the 27 motifs were found in the promoter factor-dependent myeloid leukemic cell line, TF-1 (16). The CAT assay from cells harvested 24 h after transfection demonstrated a 12-fold increase in transcriptional activity of the promoter construct compared to the vector alone (Fig. 3) . The percentage acetylation of the 01000 p55CdcCAT plasmid was 11.7, compared to 1.1 of the vector control. Our results indicate that the 01000 nt region of the promoter is functional in transient transfection assays. The CMV b-galactosidase assay did not demonstrate an appreciable difference between the vector control and the promoter construct (1.16 versus 1.39, respectively). These results were confirmed in three independent experiments (data not shown).
Localization of the Human p55Cdc Gene
To localize p55Cdc to a human chromosome, we performed radiation hybrid mapping of the p55Cdc gene. Primers were designed to amplify a 193-bp fragment from human genomic DNA (17). The position was indicated to be 4.7cR from CHLC.GA-TA81C04 and 3.2cR from WI-9905 on chromosome 9. On the cytogenetic map, this likely maps to 9q13-21 (Fig. 4) . This region of chromosome 9 is the most commonly deleted region in acute myeloid leukemias associated with the 9q-syndrome (13). Other abnor- the sequence CA(C/T)GTG were observed in a number of Myc-regulated candidate genes (22). The two cell cycle genes, ornithine decarboxylase and cdc25A, identified as Myc targets, contain the proposed Myc-binding site located in the introns. p55Cdc has two Myc-Max DNA recognition sequences, the first located in intron 3, and the second in exon 7. However, identification of a Myc target gene cannot be (100 U/ml)-streptomycin (100 mcg/ml) at a ratio of 1 U/ml:1 mcg/ ml in nonadherent tissue culture plates. Cells were maintained on 500 pM recombinant human GM-CSF (rhGM-CSF). The TF-1 
Enhancer Activity of the p55Cdc Promoter
